CM
UTHR icon

Crestline Management’s United Therapeutics UTHR Stock Holding History

Crestline Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,306
Closed -$3.42M – 204
2022
Q4 		$3.42M Buy
12,306
+125
+1% +$31.6K 0.5% 61
2022
Q3 		$2.55M Buy
12,181
+5,123
+73% +$1.15M 0.34% 71
2022
Q2 		$1.66M Sell
7,058
-1,601
-18% -$325K 0.22% 95
2022
Q1 		$1.55M Sell
8,659
-11,597
-57% -$2.21M 0.2% 107
2021
Q4 		$4.38M Buy
20,256
+3,014
+17% +$592K 0.33% 59
2021
Q3 		$3.18M Buy
17,242
+5,987
+53% +$1.18M 0.3% 74
2021
Q2 		$2.02M Buy
+11,255
New +$2.14M 0.17% 81
2019
Q4 		– Sell
-37,500
Closed -$2.99M – 91
2019
Q3 		$2.99M Buy
37,500
+24,500
+188% +$1.97M 0.48% 37
2019
Q2 		$1.01M Buy
+13,000
New +$1.22M 0.14% 59

Other funds holding UTHR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return